Dr. Reddy’s and Nestlé Health Science Limited, a joint venture between Dr. Reddy’s Laboratories Ltd and Nestlé India Limited, have launched Celevida® GLP+, a scientifically designed nutritional product developed to support people undergoing GLP-1/GIP therapy for the management of type 2 diabetes and obesity in India.
The launch comes at a time when GLP-1/GIP-based therapies are witnessing wider adoption for diabetes and obesity management. While these therapies improve access to advanced treatment options, experts emphasise the need for a more integrated patient-care ecosystem that extends beyond medication. Such an ecosystem should include nutrition support, clinical monitoring, and long-term patient guidance to ensure sustainable and holistic health outcomes.
Addressing Nutrition Gaps During GLP-1/GIP Therapy
Experts have increasingly highlighted the importance of addressing nutritional deficiencies and muscle health challenges associated with GLP-1/GIP therapies. According to studies, nearly 25–40% of total weight loss during GLP-1 and dual GLP-1/GIP therapies may result from the loss of lean body mass.
Senior Indian clinicians further noted that Indians may face a higher risk of muscle loss because they generally have lower baseline skeletal muscle mass and higher body fat percentages. Additionally, chronically low protein intake among Indians—estimated at around 0.6 g/kg/day—may further worsen this issue.
As a result, preserving muscle mass has become critical for maintaining long-term metabolic and functional health.
Experts Recommend Higher Protein Intake
Clinical experts and consensus guidelines recommend increasing protein intake to 1.2–1.5 g/kg/day during weight-loss therapy to help preserve muscle mass. Consequently, the need for specialised nutritional support tailored to patients on GLP-1/GIP therapy has gained significant attention.
Celevida® GLP+ Designed to Support Muscle Preservation
To address this unmet need, Dr. Reddy’s and Nestlé Health Science co-created Celevida® GLP+ with leading endocrinologists and diabetologists. The formulation aims to bridge protein gaps while helping preserve muscle mass and function in individuals undergoing GLP-1/GIP therapy.
As per the press release, the product contains fast-absorbing whey protein isolate (WPI), which is considered gentle on the gut and suitable for individuals experiencing gastrointestinal intolerance commonly associated with GLP-1/GIP therapies.
Celevida® GLP+ provides:
- 48 g of protein per 100 g
- 100% Recommended Dietary Allowance (RDA) of branched-chain amino acids (BCAAs)
- 27 essential nutrients, including vitamins A, D, and calcium
Company Leadership Highlights Integrated Patient Care
Commenting on the launch, M.V. Ramana, CEO, Global Generics at Dr. Reddy’s Laboratories Limited and Director, Dr. Reddy’s and Nestlé Health Science Limited, said:
“GLP-1 therapies represent a significant advancement in diabetes and obesity management. However, there remains a clear unmet need in supporting patients beyond pharmacological treatment, particularly in addressing nutrition gaps and preserving muscle health during therapy. As patients experience changes in body composition, ensuring adequate nutrient intake and maintaining lean body mass become essential for sustaining long-term outcomes. With Celevida® GLP+, we aim to provide a targeted, science-backed nutritional solution that complements pharmacological therapies and supports better overall patient outcomes in their everyday journey.”
He further added that the company remains committed to advancing integrated and patient-centric solutions for more sustainable metabolic health management.
Building on an Established Diabetes Nutrition Portfolio
Dr. Reddy’s and Nestlé Health Science already maintain a strong presence in specialised nutrition through Celevida® Diabetes Nutrition, which supports comprehensive diabetes management. The formulation has demonstrated benefits in supporting sustained 24-hour blood glucose control and reducing HbA1c levels. Additionally, its low glycaemic index makes it suitable for long-term metabolic management.
Availability
Celevida® GLP+ is available in a 350 g pack across pharmacies, retail outlets, and leading e-commerce platforms across India.